Difference between revisions of "P63"

From Libre Pathology
Jump to navigation Jump to search
(re-order)
Line 1: Line 1:
[[Image:High_grade_squamous_intraepithelial_lesion_-_2_-_p63_--_intermed_mag.jpg |thumb|right|350px| Nuclear staining is characteristic of p63.]]
{{ Infobox immunostain
| Name      = {{PAGENAME}}
| Image     = High_grade_squamous_intraepithelial_lesion_-_2_-_p63_--_intermed_mag.jpg
| Width      =
| Caption    = p63 staining in squamous epithelium with dysplasia.
| Abbrev    =
| Synonyms  =
| Similar    = p40 (more specific for squamous cell carcinoma)
| Clones    =     
| Use        = breast pathology (invasion vs. in situ), prostate pathology (HGPIN vs. cancer), lung (adenocarcinoma vs. squamous)
| Subspecial = 
| Pattern    = nuclear staining
| Positive  = [[squamous cell carcinoma]], [[urothelial carcinoma]]
| Negative  = [[prostate carcinoma]], most [[lung adenocarcinoma]], breast carcinoma
| Other      =
}}
'''p63''' is a commonly used [[immunostain]].  p63, like most other "p" stains, is a nuclear stain.
'''p63''' is a commonly used [[immunostain]].  p63, like most other "p" stains, is a nuclear stain.



Revision as of 02:16, 23 September 2015

P63
Immunostain in short

p63 staining in squamous epithelium with dysplasia.
Similar stains p40 (more specific for squamous cell carcinoma)
Use breast pathology (invasion vs. in situ), prostate pathology (HGPIN vs. cancer), lung (adenocarcinoma vs. squamous)
Normal staining pattern nuclear staining
Positive squamous cell carcinoma, urothelial carcinoma
Negative prostate carcinoma, most lung adenocarcinoma, breast carcinoma

p63 is a commonly used immunostain. p63, like most other "p" stains, is a nuclear stain.

Pattern

  • Nuclear staining.

Note:

Classic use

Subtype marker:

Thresholding (invasive vs. pre-invasive):

  • Prostate basal cell marker.
  • Breast myoepithelial cell marker.

Non-classic tumours

See also

References

  1. Martin, SE.; Temm, CJ.; Goheen, MP.; Ulbright, TM.; Hattab, EM. (Oct 2011). "Cytoplasmic p63 immunohistochemistry is a useful marker for muscle differentiation: an immunohistochemical and immunoelectron microscopic study.". Mod Pathol 24 (10): 1320-6. doi:10.1038/modpathol.2011.89. PMID 21623385.
  2. Lewis, JS.; Ritter, JH.; El-Mofty, S. (Nov 2005). "Alternative epithelial markers in sarcomatoid carcinomas of the head and neck, lung, and bladder-p63, MOC-31, and TTF-1.". Mod Pathol 18 (11): 1471-81. doi:10.1038/modpathol.3800451. PMID 15976812.
  3. Di Como, CJ.; Urist, MJ.; Babayan, I.; Drobnjak, M.; Hedvat, CV.; Teruya-Feldstein, J.; Pohar, K.; Hoos, A. et al. (Feb 2002). "p63 expression profiles in human normal and tumor tissues.". Clin Cancer Res 8 (2): 494-501. PMID 11839669.
  4. Jo, VY.; Fletcher, CD. (Nov 2011). "p63 immunohistochemical staining is limited in soft tissue tumors.". Am J Clin Pathol 136 (5): 762-6. doi:10.1309/AJCPXNUC7JZSKWEU. PMID 22031315.